Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCAMP: Antibiotic Safety in Infants With cIAI
NCT01994993Phase 3Completed
- Sponsor
- Michael Cohen-Wolkowiez
- Start
- Dec 2013
- Primary completion
- Jan 2017
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 2
01
Overview
A Phase 3 trial of metronidazole, clindamycin, piperacillin + tazobactam in Intra-abdominal infection (IAI), sponsored by Michael Cohen-Wolkowiez. Started Dec 2013; status: completed.
02
Drugs
metronidazoleclindamycinpiperacillin + tazobactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT01994993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994993.